Streetbeat News

Stock Prices

IART

Analyst ratings for Integra Lifesciences (NASDAQ:IART) show a mix of sentiments, with recent adjustments reflecting a bearish outlook. The average 12-month price target is now $33.5, down 23.2% from the previous $43.62. Analysts from firms like Morgan Stanley, JMP Securities, and Wells Fargo have lowered their price targets, indicating concerns over the company's market position and financial health. Despite a strong net margin and ROE, Integra faces challenges with negative revenue trends and a market capitalization below industry benchmarks.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 7:00 pm

FYBR

Four analysts have recently reviewed Frontier Communications (NASDAQ:FYBR), showing a unanimous bullish stance with an average 12-month price target of $32.75, down from $33.00. The company's financial performance indicates a strong revenue growth rate of 1.97% as of March 31, 2024, but struggles with net margin and ROA. Analysts' actions, including ratings and price target adjustments, reflect their optimistic view on FYBR despite its lower market capitalization and profitability challenges.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 7:00 pm

KIDS

OrthoPediatrics (NASDAQ:KIDS) has received mixed analyst ratings over the past quarter, with a recent positive shift in the 12-month price target to $40.29, up 20.88% from $33.33. Analysts from firms like Needham, JMP Securities, and Truist Securities have updated their ratings and price targets, reflecting a bullish to indifferent sentiment. The company, specializing in pediatric orthopedic devices, shows a positive revenue trend with a growth rate of 21.36% as of December 31, 2023, but struggles with profitability, having a net margin of -17.79%. Despite this, its ROE and prudent debt management indicate strong financial performance and a balanced approach to debt.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 7:00 pm

LINKUSD

Chainlink (CRYPTO: LINK) has seen a price decrease of 3.01% in the last 24 hours, now at $14.27, despite a 10% increase over the past week from $12.98. The trading volume fell by 14%, while the circulating supply rose by 0.23% to 587.10 million, 58.71% of its max supply. LINK's market cap ranks #18 at $8.36 billion.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 7:00 pm

AGRI

BVS

GLDD

GSUN

JELD

NUWE

STIM

Nasdaq fell by 0.2% while Great Lakes Dredge & Dock Corp. shares surged 24% after reporting better-than-expected Q1 earnings. Other notable movements included Nuwellis, Bioventus, and Golden Sun Health Technology shares rising significantly, whereas AgriFORCE Growing Systems, JELD-WEN Holding, and Neuronetics saw substantial declines.

Portfolio Pulse from Avi Kapoor

May 07, 2024 | 6:58 pm

WAT

Waters Corp (NYSE:WAT) reported Q1 2024 sales of $636.8 million, surpassing analyst expectations. Despite a 7% revenue decline, adjusted EPS was $2.21, beating estimates. Sales varied by region, with a notable 18% decrease in Asia. The company expects full-year 2024 sales growth between -0.5% to +1.5% and maintains its adjusted EPS forecast. WAT shares rose 1.88% to $325.59.

Portfolio Pulse from Anusuya Lahiri

May 07, 2024 | 6:55 pm

PTLO

Portillo's shares are trading lower due to worse-than-expected Q1 sales results.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 6:53 pm

MSFT

NVDA

Stanley Druckenmiller, a billionaire investor and former employee of George Soros, has reduced his investment in Nvidia Corp (NVDA) after the stock's significant surge, attributing the decision to the rapid acceleration of the AI market. Druckenmiller, who has been investing in AI through stocks like Nvidia and Microsoft Corp (MSFT), cited Nvidia's stock price increase from $150 to over $900 in just over a year as a reason for the reduction. Despite this, he remains bullish on AI's long-term prospects, comparing its potential impact to that of the internet.

Portfolio Pulse from Adam Eckert

May 07, 2024 | 6:49 pm

IMAB

I-MAB's (NYSE:IMAB) short interest has significantly increased by 113.98% since the last report, with 1.30 million shares sold short, representing 3.98% of its float. This indicates a bearish market sentiment towards IMAB, despite the short interest being lower than its peer group average of 9.63%. The current short interest suggests it would take approximately 5.85 days for traders to cover their positions, based on recent trading volumes.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 6:45 pm

MYSZ

My Size, Inc. (NYSE:MYSZ) has seen a significant increase in short interest, with a 2063.64% rise since the last report, representing 7.14% of its float. This indicates a bearish market sentiment towards MYSZ, although it's not a definitive predictor of stock price movement. The short interest in MYSZ is higher than its peer group average of 4.84%, suggesting more bearish sentiment compared to its peers.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 6:45 pm